Clinical Study
HLA Markers for Poor Prognosis in Systemic Sclerosis Brazilian Patients
Table 4
Risk and protective alleles for pulmonary fibrosis.
| ||||||||||||||||||||||||||||||||
95% CI: 95% confidence intervals; PR: prevalence ratio; *univariate values calculated with Chi-square and Fisher’s exact tests where appropriate. The PR and values were obtained by comparing patients with and without PF and PAH. |